Arthritis and bursitis in multiple sclerosis patients treated with interferon‐beta

Author： Strueby L. Nair B. Kirk A. Taylor R. M.

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.34, Iss.6, 2005-11, pp. : 485-488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching to Second-Line Therapies in Interferon-Beta-Treated Relapsing-Remitting Multiple Sclerosis Patients

European Neurology, Vol. 61, Iss. 3, 2009-01 ,pp. : 177-182

Karger

Access to resources Recommend Favorite

Prognostic Value of Soluble Tumor Necrosis Factor Receptors 1 and 2 in Multiple Sclerosis Patients Treated with Interferon Beta-1b

European Neurology, Vol. 46, Iss. 4, 2001-11 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

The Treatment of Multiple Sclerosis with Beta-Interferon

Neuroepidemiology, Vol. 31, Iss. 3, 2008-08 ,pp. : 157-158

Karger

Access to resources Recommend Favorite

Coping Strategy and Anxiety Evolution in Multiple Sclerosis Patients Initiating Interferon-Beta Treatment

European Neurology, Vol. 62, Iss. 2, 2009-06 ,pp. : 79-85

Karger

Access to resources Recommend Favorite

Beta-Interferon Protects Multiple Sclerosis Patients against Enhanced Susceptibility to Infections Caused by Poor Air Quality

Neuroepidemiology, Vol. 30, Iss. 1, 2008-01 ,pp. : 13-19

Karger

Access to resources Recommend Favorite